Stocktoria
ASTROTECH Corp ASTC
ASTROTECH Corp (ASTC) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $1.0M at a -1320.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ASTC | ASTROTECH Corp | 2/9 | — | — | — |
| SEER | Seer, Inc. | 3/9 | 4.62 | — | +17% |
| BNGO | Bionano Genomics, Inc. | 3/9 | — | — | -7.4% |
| EYPT | EyePoint, Inc. | 1/9 | -3.58 | — | -27.5% |
| RPID | RAPID MICRO BIOSYSTEMS, INC. | 2/9 | — | — | +19.7% |
| PRPO | Precipio, Inc. | 7/9 | -13.13 | — | +28% |
| HBIO | HARVARD BIOSCIENCE INC | 4/9 | -10.45 | — | -8.1% |
About ASTROTECH Corp
Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, and law enforcement centers. In addition, it develops AGLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath; and Pro-Control 1000-D2, a mass spectrometer; and EN-SCAN to detect soil, water, and air contamination source location and migration. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.
FAQ
Is ASTC financially healthy?
ASTROTECH Corp's Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).
Does ASTC pay a dividend?
No, ASTROTECH Corp does not currently pay a dividend.
How profitable is ASTC?
In FY2025, ASTROTECH Corp had a net margin of -1320.3% and a return on equity of -62.7%.
Is ASTC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on ASTROTECH Corp: a Piotroski F-score of 2/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.